James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Strange Bedfellows: PDLI Fuses Dividends With Biopharma

Looking to diversify your dividends? PDLI is one of the only names that can drive income from biopharma sales.

Was Carl Icahn Right About the PayPal Spinoff? (EBAY)

Resurfaced rumors of eBay considering a PayPal spinoff have lit a fire under EBAY stock, and rightfully so.

Alibaba IPO – The Timing Couldn’t Be Any Better

The planets are aligning for the Alibaba IPO, even if it's going to take time for BABA stock to grow into its valuation.

Has the QQQ Reached a Tipping Point?

After Monday’s bullish burst, the QQQ ETF looks like a trade worth chasing. There are a few things would-be investors need to know first, though.

Sears Holdings – Q2 Earnings Won’t Save the Day

Sears Holdings' earnings report is likely to show more of the same problems Eddie Lampert has been facing for years -- not a comeback for SHLD stock.